Patient M.K. was one of the first patient to use IBDoc world wide during an early project in Vienna. M.K. is suffering from Crohn’s Disease and after the first couple of months of using IBDoc we received following statement:
IBDoc News
A blog article about IBDoc® has been published on the Gastroenterology & Endoscopy News website, a No. 1-rated independent monthly newspaper providing news and information for nearly 18,000 gastroenterologists, colorectal surgeons, hepatologists, physician assistants and nurse practitioners. In the article Toronto-based medical journalist David Wild looked at the IBDoc® system and interviewed Dr. Peter Higgins, MD, the director
Basel, April 2nd, 2015 – BÜHLMANN is pleased to announce the launch of IBDoc®, the first in-vitro diagnostic test to measure the fecal inflammation marker calprotectin at home. IBDoc® just received a CE mark for patient self testing and is a revolutionary new test for gut inflammation aimed at people with Inflammatory Bowel Disease, Crohn’s and Ulcerative Colitis
Thank you for finding your way to this first blogpost from ibdoc.net. What is ibdoc.net? To understand that, you need to know first a few things about IBD, calprotectin and BÜHLMANN Laboratories AG, situated in Schönenbuch close to Basel, Switzerland. BÜHLMANN is well known for its faecal calprotectin tests, which are used by many medical